03.12.19

Aerie Pharmaceuticals Receives FDA Approval of Rocklatan for Reduction of IOP

Source: Aerie Pharmaceuticals

01.14.19

Glaucoma Drug Reduces IOP Spike After Anti-VEGF Injections

Source: Reuters

01.14.19

Take Diabetes Into Consideration When Assessing for Glaucoma

Source: Medscape

01.07.19

Allergan Announces Positive 3-Month Topline Results from Second Phase 3 Study of Bimatoprost SR Implant for Lowering IOP

Source: Allergan

12.14.18

Higher Eye Pressure After Anti-VEGF Therapy Needs More Attention

Source: Reuters

12.03.18

First Patient Successfully Implanted with Implandata’s Eye Pressure Sensor for Continual Glaucoma Monitoring

Source: Implandata

11.17.17

Successful First-in-Human Testing of Implandata’s Next-Generation Eyemate Micro-Sensor for Improved Monitoring of Glaucoma Patients

Source: Implandata

View more stories